Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).
Conditions: Multiple Sclerosis, Secondary Progressive; Multiple Sclerosis Interventions: Drug: Cladribine Subcutaneous Injection; Drug: 0.9% Chloride Injection Sodium Sponsors: Institute of Psychiatry and Neurology, Warsaw; Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences; Mossakowski Medical Research Centre Polish Academy of Sciences; Poznan University of Medical Sciences; Military Institute of Aviation Medicine Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Biomedical Engineering | Brain | Multiple Sclerosis | Neurology | Poland Health | Psychiatry | Research | Sodium